The intestinal epithelium is the most rapidly self-renewing tissue in adult mammals, which renews every 3--5 days in mice.^[@bib1]^ Homeostasis of the intestinal epithelium is dependent on intestinal stem cells (ISCs) and a balance among cell proliferation, migration, differentiation, and cell death.^[@bib1],\ [@bib2]^ Several ISC populations with possible overlap have recently been identified in mouse, including the actively cycling columnar cells at the crypt base (CBCs) marked by Lgr5 or CD133, and the slow cycling cells in the +4 area marked by Bmi1, DCLK-1 (also known as DCAMKL-1), or mTERT. Ablation of certain lineage revealed inter-conversion of ISC populations and re-establishment of more diverse ISC populations upon repair.^[@bib3]^ Epithelial injury and compromised repair have been linked to a wide range of diseases, including chronic inflammation, autoimmunity, and cancer. Developmental pathways, such as Wnt/*β*-catenin, BMP, PI3K, and Notch, are important in the maintenance of ISCs and intestinal proliferation and differentiation,^[@bib4]^ whereas the role of other pathways remain largely unexplored and can help illuminate pathogenesis of these diseases.

Adenosine-to-inosine (A-to-I) editing of primary transcripts by ADAR enzymes (adenosine deaminase acting on RNA) is the most prevalent RNA-editing mechanism in higher eukaryotes.^[@bib5],\ [@bib6]^ Three mammalian adenosine deaminase acting on RNA (ADAR) genes are found in mammals, which encode two active deaminases (ADAR1 and ADAR2) and one inactive deaminase (ADAR3).^[@bib5],\ [@bib6]^ ADARs act on double-stranded RNA (dsRNA) structures in both messenger and noncoding RNAs. The A--to-I conversion in dsRNA alters the stabilities of the dsRNA helix, and can also lead to codon changes as I is decoded as guanosine (G) during translation that increases transcriptomic diversity.^[@bib6],\ [@bib7]^ ADARs also edit noncoding RNAs to affect microRNA processing,^[@bib7]^ as well as sites scattered in Alu repeat elements within human pre-mRNAs.^[@bib8]^ ADARs also catalyze hyper-editing of long dsRNAs, whereby up to 50% of adenosines are converted to inosine (I).^[@bib9]^

*ADAR1* is mutated in a rare autosomal-dominant human-inherited skin pigmentation disease called dyschromatosis symmetrica hereditaria, and over 90 mutations have been identified in patients.^[@bib10]^ Most of these mutations are predicted to produce truncated proteins. In mice, *ADAR1* deletion causes widespread apoptosis, defective hematopoiesis, and embryonic lethality, suggesting an essential role of ADAR1 for embryo development and cell proliferation and differentiation.^[@bib11],\ [@bib12]^ Using conditional knockout models, ADAR1 was found to be required for the maintenance of hematopoietic stem cells and hematopoietic progenitor cells^[@bib13],\ [@bib14]^ by suppression of interferon (IFN) signaling.^[@bib13],\ [@bib15]^ Loss of *ADAR1* in the skin led to massive cell death in the epidermis and loss of hair follicles.^[@bib16]^

In this study, we investigated the role of ADAR1 in the intestinal tract using a conditional knockout mouse model. *ADAR1* was expressed highly in the Lgr5+ population, and its deletion in adult mice induced a rapid apoptosis and loss of stem cells in the small intestine and colon. *ADAR1* deletion led to marked changes in intestinal differentiation, an expansion of transient amplification (TA) cells, and severe intestinal injury and inflammation. Loss of *ADAR1* induced endoplasmic reticulum (ER) stress and IFN signaling in intestinal epithelial cells. Data from cultured crypts strongly suggest that ADAR1 suppresses epithelial cell death through a cell-autonomous manner. These data reveal a critical role of ADAR1 in maintaining intestinal homeostasis and ISC survival, and a potential involvement of RNA editing in digestive diseases.

Results
=======

*ADAR1* loss leads to crypt apoptosis and intestinal damage in mice
-------------------------------------------------------------------

To investigate the role of ADAR1 in the small intestine, 6- to 10-week-old CreER; ADAR1^f/f^ mice were administered with 120 mg/kg tamoxifen on day 0, 1, 3, and 4 to excise floxed *ADAR1* alleles ([Supplementary Figure 1A](#sup1){ref-type="supplementary-material"}). ADAR1^f/f^ mice treated with tamoxifen were used as controls in all experiments. The deletion efficiency of *ADAR1* in the small intestine mucosa was over 50 and 70% on day 3 and 5, respectively in CreER; ADAR1^f/f^ mice ([Figure 1a](#fig1){ref-type="fig"}). Western blotting confirmed reduction of ADAR1 protein ([Figure 1a](#fig1){ref-type="fig"}). *ADAR1* deletion can be detected on day 1 (1 × TM), whereas the deletion efficiency on day 2 and 3 (2x TM) were similar as expected ([Figure 1a](#fig1){ref-type="fig"} and [Supplementary Figure 1B](#sup1){ref-type="supplementary-material"}). Based on these observations and a 3--5 day renewal cycle of intestinal epithelium,^[@bib1],\ [@bib2]^ we examined tissue harvested on or before day 5 in our following analyses.

There was no discernable difference in the histology of the small intestine between ADAR1^f/f^ and CreER; ADAR1^f/f^ mice without tamoxifen treatment ([Figure 1b](#fig1){ref-type="fig"}). However, tamoxifen treatment resulted in shortened villi in CreER; ADAR1^f/f^ mice on day 3, and a severe loss of crypts and epithelial integrity on day 5. Terminal deoxynucleotidyl transferase-mediated deoxyuridinetriphosphate nick end labeling (TUNEL) staining and active caspase 3 immunohistochemical (IHC) indicated apoptosis in the intestinal crypts ([Figures 1c--e](#fig1){ref-type="fig"}). Notably, apoptosis was concentrated in the bottom of crypts ([Supplementary Figures 1C and D](#sup1){ref-type="supplementary-material"}) and could be detected as early as day 2 in the CBC area, whereas little or no apoptosis was detected in the villi ([Supplementary Figures 1E and F](#sup1){ref-type="supplementary-material"}). *ADAR1* deletion resulted in significant crypt loss accompanied by crypt fission in the colon on day 5 ([Supplementary Figure 2A](#sup1){ref-type="supplementary-material"}), which was not pronounced on day 3. TUNEL staining confirmed induction of cell death in the colonic crypts ([Figure 1f](#fig1){ref-type="fig"}, [Supplementary Figures 2B and C](#sup1){ref-type="supplementary-material"}).

Furthermore, we examined the effect of *ADAR1* deletion on the stomach, bone marrow, and spleen. Significant cell death in CreER; ADAR1^f/f^ was detected on day 5, accompanied by apparent hypo-cellularity and damage ([Supplementary Figure 3](#sup1){ref-type="supplementary-material"}). Little or no structural changes or cell death were detected in all organs examined in ADAR1^f/f^ mice ([Supplementary Figure 3](#sup1){ref-type="supplementary-material"}). These results demonstrate that ADAR1 has an important role in the homeostasis of GI tract and hematopoietic system, which are highly proliferative and contain a well-defined stem cell compartment.

ADAR1 is required for maintenance of ISCs
-----------------------------------------

To probe a potential role of ADAR1 in ISC survival, we analyzed the expression of a robust CBC marker Olfm4 by RNA *in situ* hybridization (ISH).^[@bib17]^ *Olfm4* expression (blue) was restricted in crypt bottom and CBCs areas in CreER; ADAR1^f/f^ and control mice ([Figure 2a](#fig2){ref-type="fig"}). Tamoxifen treatment induced a significant loss of *Olfm4* signals, especially in between the Paneth cells in CreER; ADAR1^f/f^ mice on day 3 and by 80% on day 5 ([Figures 2a and b](#fig2){ref-type="fig"}). The mRNA level of *Lgr5* (Leucine-rich repeat-containing G-protein coupled receptor 5), but not that of the +4 cell-marker Bmi1, was decreased on day 2, before massive epithelial injury was detected ([Figure 2b](#fig2){ref-type="fig"}). Importantly, TUNEL staining co-localized with Olfm4 *ISH* ([Figures 2c](#fig2){ref-type="fig"} and [Supplementary Figure 4A](#sup1){ref-type="supplementary-material"}). RT-PCR analysis showed that *ADAR1* was expressed highly in Lgr5 high population compared with Lgr5 low or unfractionated crypts ([Figure 2e](#fig2){ref-type="fig"}). Loss of Paneth cells under certain conditions can lead to loss of Lgr5+ or Olfm4+ cells.^[@bib18]^ However, cell death was not detected in Paneth cells on day 3 or 5 ([Supplementary Figure 4B](#sup1){ref-type="supplementary-material"} and data not shown). Loss of Olfm4+ or increase in TUNEL+ cells was not observed in control mice ([Figure 2](#fig2){ref-type="fig"} and [Supplementary Figure 4](#sup1){ref-type="supplementary-material"}). These data demonstrate that ADAR1 selectively suppresses cell death in actively cycling ISCs.

*ADAR1* loss impairs intestinal differentiation
-----------------------------------------------

Differentiaton can be used to measure stem cell quality. We examined four major differentiated intestinal epithelial lineages using established markers. Tamoxifen treatment induced a sharp decrease in the numbers of enterocytes, goblet cells, and enteroendocrine cells in CreER; ADAR1^f/f^ mice on days 3 and 5 ([Figures 3a](#fig3){ref-type="fig"}, and [Supplementary Figure 5](#sup1){ref-type="supplementary-material"}). In contrast, a drastic expansion and mislocalization of Paneth cells was observed ([Figures 3a and b](#fig3){ref-type="fig"}, and [Supplementary Figure 6](#sup1){ref-type="supplementary-material"}). These changes were absent in ADAR1^f/f^ mice, suggesting *ADAR1* deletion impairs differentiation of progenitor or TA cells.

Given a key role of Wnt/*β*-catenin pathway in intestinal homeostasis, proliferation, and differentiation,^[@bib19]^ we examined the effects of *ADAR1* deletion on the expression of several Wnt targets using quantitative RT-PCR. These include *cyclinD1, c-Myc, EphB2, EphB3, Lef1, Cdx1, Sox9, and Wnt 3A*. Among them, *c-Myc*, *Sox9, EphB2, EphB3, and Lef1*, were significantly induced in the mucosa of CreER; ADAR1^f/f^ mice by day 3, compared with ADAR1^f/f^ mice. The increased expression of Sox9 and c-Myc was most notable ([Figure 3c](#fig3){ref-type="fig"}). Immunostaining revealed a drastic expansion of Sox9+ cells ([Figure 3d](#fig3){ref-type="fig"} and [Supplementary Figure 6D](#sup1){ref-type="supplementary-material"}) and bromodeoxyuridine+ (BrdU+) cells ([Figures 3e and f](#fig3){ref-type="fig"}). In addition, the expression of editing defective *ADAR1* mutant 910K/912E significantly activated the TCF4 reporter in HCT 116 colon cancer cells. However, the expression of WT ADAR1 did not suppress elevated basal activity of TCF reporter because of *APC* mutation in these cells^[@bib20]^ ([Figure 3d](#fig3){ref-type="fig"} and [Supplementary Figure 6E](#sup1){ref-type="supplementary-material"}). These data suggest that *ADAR1* deletion leads to an expansion of progenitors and skewed Paneth cell fate, associated with abnormal Wnt signaling.

*ADAR1* deletion induces ER stress and activation of IFN signaling in the intestinal epithelium
-----------------------------------------------------------------------------------------------

ER stress can induce death in the intestinal epithelial cells,^[@bib21]^ which is associated with decreased number of goblet cells, and expansion and mislocalization of Paneth cells.^[@bib22],\ [@bib23],\ [@bib24],\ [@bib25]^ To test a potential role of ER stress in cell death following *ADAR1* deletion, we measured several markers of ER stress such as glucose-regulating peptide 78 (Bip) and C/EBP homologous protein (CHOP).^[@bib21]^ Tamoxifen administration induced Bip and CHOP in the mucosa of CreER; ADAR1^f/f^ mice, compared with control mice ([Figure 4a](#fig4){ref-type="fig"}). Furthermore, administration of an ER stress inhibitor Salubrinal blunted cell death ([Figure 4b](#fig4){ref-type="fig"}) and the expression of Bip and CHOP ([Figures 4c and d](#fig4){ref-type="fig"}).

ADAR1 suppresses IFN signaling in hematopoietic stem cells,^[@bib13]^ whereas IFNs can induce apoptosis through the ER stress pathway.^[@bib26],\ [@bib27],\ [@bib28]^ We therefore examined a panel of IFN-regulated genes by quantitative RT-PCR in intestinal mucosa and isolated crypts, following *ADAR1* deletion. These genes include the signal transducers and activators of transcription 1 (STAT), the IFN regulatory factors IRF7 and IRF9, the RNA-activated protein kinase PKR, and the IFN-induced proteins Ifi35.^[@bib13]^ IRF-7, STAT1, and PKR, but not IRF9 and Ifi35, were significantly induced in the crypts of CreER; ADAR1^f/f^ mice as early as day 2 or day 1, compared with control mice ([Figures 4e](#fig4){ref-type="fig"} and [Supplementary Figure 7](#sup1){ref-type="supplementary-material"}), which preceded apoptosis ([Figure 1](#fig1){ref-type="fig"}). These data indicate that *ADAR1* deletion lead to ER stress and activation of IFN signaling to induce intestinal epithelial cell death.

*ADAR1* deletion induces intestinal inflammation
------------------------------------------------

*ADAR1* deletion induced progressive intestinal epithelial damage and inflammation in the lamina propria and submucosa ([Figure 1b](#fig1){ref-type="fig"}). To rule out immune cell infiltration as a primary cause of the IFN signaling or ER stress, we examined major immune cell types in the intestine by immunostaining, including neutrophils, T (Cd3e+), B (B220+), and myeloid (Ly6G+) cells. Increased infiltration of neutrophils, T, and B cells, but not myeloid cells, was present in the lamina propria of CreER; ADAR1^f/f^ mice on day 3 and 5 after tamoxifen treatment ([Figure 5](#fig5){ref-type="fig"} and [Supplementary Figure 8](#sup1){ref-type="supplementary-material"}). Consistent with intestinal inflammation, the expression of inflammatory cytokines *IL-1α, IL-1β*, *IL-6*, and *TNFα* was significantly elevated in the small intestinal mucosa on day 5 ([Figures 5e and f](#fig5){ref-type="fig"}). Interestingly, induction of *IL-6* and *TNFα* was detected as early as day 2 in both mucosa and isolated crypts, before immune cell infiltration ([Figures 5e and 5f](#fig5){ref-type="fig"}, and data not shown). The expression of leukocyte adhesion molecules *ICAM-1* and *VCAM-1* did not change ([Figures 5e and f](#fig5){ref-type="fig"}). Little or no change in intestinal inflammation was present in ADAR1^f/f^ mice ([Figure 5](#fig5){ref-type="fig"} and [Supplementary Figure 8](#sup1){ref-type="supplementary-material"}). These results demonstrated that immune cell infiltration occurs primarily after ISC apoptosis following ADAR1 deletion and likely exacerbates intestinal injury.

Loss of *ADAR1* induces apoptosis in isolated intestinal crypt cells
--------------------------------------------------------------------

To directly investigate a role of ADAR1 in the intestinal epithelial cells, we cultured intestinal crypts isolated from mice, and induced *ADAR1* deletion *in vitro*. Tamoxifen treatment (1 or 2 nM) induced massive apoptosis in cultured crypts from CreER; ADAR1^f/f^ mice within 24 h, but not in those from the control mice ([Figure 6a](#fig6){ref-type="fig"} and [Supplementary Figure 9A;](#sup1){ref-type="supplementary-material"} [Figure 6b](#fig6){ref-type="fig"} and [Supplementary Figure 9B](#sup1){ref-type="supplementary-material"}). Apoptosis was correlated with decreased expression of *Lgr5,* but not *Bmi1* ([Figure 6c](#fig6){ref-type="fig"}). Consistent with our *in vivo* data, ablation of *ADAR1* in cultured crypts also led to a dramatic increase in *c-Myc* and *Sox9* ([Figure 6d](#fig6){ref-type="fig"}), CHOP ([Figure 6e](#fig6){ref-type="fig"} and [Supplementary Figure 9C](#sup1){ref-type="supplementary-material"}), and induction of IFN-regulated genes ([Figure 6f](#fig6){ref-type="fig"}). A significant reduction in *Wnt 3A* was also observed following *ADAR1* deletion ([Figure 6d](#fig6){ref-type="fig"}), and could potentially contribute to ISC loss or the lack of crypt growth.^[@bib18]^ Moreover, changes in Wnt targets including *c-Myc*, *Sox9, and Wnt 3A* following *ADAR1* deletion differed significantly in the intestinal crypts, MEFs, and hepatocytes ([Supplementary Figure 10](#sup1){ref-type="supplementary-material"}). These data strongly suggest that ADAR1 suppresses ER stress and IFN signaling to maintain crypt survival and intestinal lineage commitment.

Discussion
==========

Intestinal epithelial injury, particularly that related to the stem cells^[@bib29]^ and ER stress,^[@bib21]^ is implicated in common digestive diseases, including inflammatory bowl diseases and inflammation-associated cancer.^[@bib30]^ Developmental pathways such as Wnt/*β*-catenin, BMP, and Notch are important in the maintenance of ISCs and intestinal homeostasis. In contrast, the p53/PUMA/p21 axis has a key role in the survival and regeneration of ISCs following radiation injury, but is largely dispensable for ISC survival and homeostasis.^[@bib2],\ [@bib31],\ [@bib32]^ In this study, we discovered an essential role of the RNA-editing enzyme ADAR1 in maintaining intestinal homeostasis and stem cells using whole mouse and isolate crypts. To our knowledge, this is the first report on the requirement of RNA-editing enzymes in intestinal homeostasis and supports that active cycling CBCs are responsible for epithelial renewal under homeostasis.^[@bib1]^ Furthermore, ADAR1 appears to have an important role in the maintenance of active stem cells and early progenitors in hematopoietic system^[@bib13],\ [@bib14]^ and skin,^[@bib16]^ whereas its role in more quiescent stem cells remains to be explored.

ADAR1 and cell death
--------------------

Both IFN signaling^[@bib13]^ and ER stress are likely involved in the cell death triggered by *ADAR1* deletion, and linked to a variety of human conditions including intestinal epithelial injury and inflammation.^[@bib21],\ [@bib33]^ In mice, targeted deletion of the ER stress response transcription factor X-box-binding protein 1, ER stress protein inositol-requiring enzyme 1*β*, or missense mutations of *Muc2* or deletion of Anterior Gradient 2 (*AGR2*) cause ER stress and death of intestinal epithelial cells in mice.^[@bib22],\ [@bib23],\ [@bib24],\ [@bib25]^ Editing-defective tRNA synthetase causes protein misfolding and ER stress in neurons.^[@bib34]^ The sensitivity of intestinal epithelium to ER stress might be explained by the rapid proliferation of TA cells or progentiors, the presence of several secretory lineages and polarized enterocytes, demanding a highly funtional secretory pathway. The mechanism by which ADAR1 suppresses IFN signaling is not known, and both RNA editing^[@bib7],\ [@bib10],\ [@bib15]^ or non-editing^[@bib35]^ functions might be involved. Recently, hyper-edited dsRNAs (IU-dsRNAs) was shown to suppress the induction of IFN-stimulated genes and apoptosis induced by poly(IC),^[@bib9]^ which can cross talk with ER stress pathway.^[@bib26],\ [@bib27],\ [@bib28]^ It will be interesting to determine whether IFN signaling engages ER stress to promote ISC death or whether these two pathways act independently upon the loss of ADAR1.

ADAR1 and differentiation
-------------------------

The Wnt/*β*-catenin pathway is the master regulator of intestinal homeostasis.^[@bib36]^ Loss of *ADAR1* led to upregulation of Wnt targets *c-Myc* and *Sox9* in the intestinal epithelium and crypts. It is possible that c-Myc is involved in both the proliferation and cell death^[@bib36]^ following *ADAR1* deletion. *Sox9* is required for the differentiation of Paneth cells.^[@bib37]^ Expansion of Sox9+ cells might help explain the large increase of Paneth cells and TA cells, whereas goblet, enteroendocrine, and enterocyte lineages were diminished. However, the increase in TA cells might also reflect a compensatory proliferation of progenitors or quiescent stem populations trigged by CBC depletion. The minor but distinct skin pigmentation phenotypes in the dyschromatosis symmetrica hereditaria individuals attributable to the loss of melanocytes^[@bib10]^ perhaps suggest another lineage-specific effect of *ADAR1*.

ADAR1 in intestinal injury and inflammation
-------------------------------------------

Apoptosis of ISCs and impaired differentiation can certainly contribute to intestinal inflammation following *ADAR1* deletion. Persistent IFN signaling, production of inflammatory cytokines, ER stress and possibly a feed-forward loop among them are likely to exacerbate intestinal inflammation. Our data suggest that the intestinal epithelial or crypt cells, rather than the immune cells, are the primary source of these signals. However, we could not exclude the possibility that *ADAR1* deletion in other cell types contributes to or exacerbates ISC loss. Given the dynamic nature of microbial interactions with host immune and epithelial cells, further exploration of *ADAR1* conditional and intestinal inflammation models should shed more light on the roles of the unfolded protein response/ER stress and IFN signaling in inflammatory bowel disease.^[@bib21],\ [@bib33]^

The role of A-to-I editing in the etiology or progression of human diseases is emerging,^[@bib7],\ [@bib10]^ and so is that of epithelial and stem cell apoptosis^[@bib38]^ and ER stress in IBD.^[@bib21]^ Our studies demonstrated an essential role of ADAR1 in ISC survival and maintenance, and intestinal homeostasis, likely requiring RNA editing much like other systems.^[@bib5],\ [@bib39]^ Future work is needed to understand the precise role and mechanisms of ADAR1 in the GI epithelium, which might lead to new targets for disease intervention or treatment.

Materials and Methods
=====================

Mice and treatment
------------------

The procedures for all animal experiments were approved by the Institutional Animal Care and Use Committee at the University of Pittsburgh. CreER; ADAR1^flox/flox^ (CreER; ADAR1^f/f^ ) and ADAR1^f/f^ littermates were generated from CreER; ADAR1^f/f^ and ADAR1^f/f^ crosses, and genotyping was performed as described.^[@bib16]^ CreER (CAG-CreER is expressed in various developing and adult tissues, Jackson laboratory, Bar Harbor, ME, USA, stock 004453); ADAR1^f/f[@bib16]^ mice were generated via two backcrosses with C57BL/6J (B6-F2). The Lgr5-EGFP (Lgr5-EGFP-IRES-creERT2) mice have been described previously.^[@bib40]^ Mice were housed in micro-isolator cages in a room illuminated from 0700 to 1900 hours (12:12-h light--dark cycle) and allowed access to water and chow *ad libitum*.

For tamoxifen treatment, tamoxifen (cat\# T5648, Sigma, St. Louis, MO, USA; 120 mg/kg) was injected intraperitoneally (i.p.) into 6- to 8-week-old mice on day 1, 2, 4, and 5. Mice were killed at various times to collect the small intestine, colon, liver, stomach, bone marrow, and spleen for histology analysis. Mice receiving the eIF2*α* inhibitor, Salubrinal (cat\#2347, R&D, Minneapolis, MN, USA),^[@bib41],\ [@bib42]^ were injected with 1 mg/kg i.p. once daily starting 1 day before tamoxifen treatment and continued until 3 days after tamoxifen treatment. All mice were injected i.p. with 100 mg/kg of BrdU (cat\# 858811, Sigma) 2 h before killing to label cells in S-phase.

Intestinal crypt culture and isolation of ISCs
----------------------------------------------

The crypt was isolated and cultured in Matrigel with supplementation of growth factors in 24-well plates for 1 day as previously described,^[@bib43],\ [@bib44]^ and subjected to tamoxifen treatment for 1 or 2 days. The intestinal crypts and Lgr5+ cells were isolated from 7- to 8-week-old Lgr5-EGFP-IRES-creERT2 mice as previously described.^[@bib40],\ [@bib43]^ Analyses on the growth of cultured crypt, immunostaing, and RT-PCR were performed. Detailed methods are found in [Supplementary Materials](#sup1){ref-type="supplementary-material"}.

Western blotting
----------------

Total protein was prepared from freshly isolated small intestine as described.^[@bib38],\ [@bib45],\ [@bib46],\ [@bib47]^ Extracts were analyzed by NuPage gel (Invitrogen, Carlsbad, CA, USA) electrophoresis.^[@bib48]^ Primary antibodies included ADAR1,^[@bib12]^ Bip (cat\#3177, Cell signaling, Danvers, MA, USA), CHOP (cat\# 2895, Cell signaling), and *β*-actin (cat\#5441, Sigma).

Total RNA extraction and real-time reverse transcriptase PCR
------------------------------------------------------------

Total RNA was prepared for tissues, isolated crypts, cultured crypts, or isolated ISCs, and cDNAs were then generated for real-time PCR analysis.^[@bib46]^

Histological analysis, TUNEL, and BrdU staining
-----------------------------------------------

Tissue was fixed in 10% formalin for 24 h and stored in 70% ETOH before processing. Sections (5 μm) from paraffin-embedded tissue were subjected to hematoxylin and eosin staining for histological analysis and various staining. Protocols for TUNEL and BrdU staining have been described.^[@bib31],\ [@bib46]^ The apoptotic or BrdU index was scored in 100 crypts or villus/mouse and reported as mean±S.D. Three or more mice were used in each group.

Alkaline phosphatase staining
-----------------------------

Paraffin-embedded tissue was sectioned (5-μm thick), rehydrated, and incubated with NBT/BCIP solution (B1911, Sigma) for 30 min. When staining was completed, slides were washed in water and mounted in Clear Mount (cat\# 17985-16, Electron Microscopy Sciences, Hatfield, PA, USA). The height of the staining in the crypt-villus units were measured and plotted relative to that in the untreated control mice.

IHC, immunofluorescent, and RNA ISH
-----------------------------------

Slides were deparaffinized, rehydrated, and treated with 3% hydrogen peroxide. Antigen retrieval was performed by boiling the sections for 10 min in 0.1 M citrate buffer antigen retrieval solution (pH 6.0). Non-specific antibody binding was blocked using 20% goat serum for 30 min. For double staining, TUNEL staining was performed after RNA ISH for *Olfm4*^[@bib17],\ [@bib38]^ or MMP7 IF staining.^[@bib49]^ Cells with positive staining were scored in at least 100 crypts or villa and reported as mean±S.D. Three or more mice were used in each group. Detailed information is found in [Supplementary Materials](#sup1){ref-type="supplementary-material"}.

Transfection and reporter assays
--------------------------------

Transfection of HCT116 human colorectal cancer cells with lipofectamine 2000 (Invitrogen) was performed using TCF4 luciferase reporter plasmids, modified Topflash and Fopflash,^[@bib50]^ transfection control pCMV*β* (Promega, Madison, WI, USA),^[@bib51]^ and WT *ADAR1*, editing defective mutant (H910K/A912E) *ADAR1*, or empty vector. All reporter experiments were performed in triplicate and repeated on at least three independent occasions. Details of transfection and ADAR1 expression constructs are found in [Supplementary Materials](#sup1){ref-type="supplementary-material"}.

Statistical analysis
--------------------

Statistical analysis was carried out using GraphPad Prism V software (San Diego, CA, USA). Data are presented as mean±S.D. Statistical significance was calculated with a Student\'s *t*-test. *P*\<0.05 was considered to be significant. The means±1 S.D. are shown in the figures where applicable.
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![*ADAR1* loss leads to crypt apoptosis and epithelial damage in the small intestine and colon in mice. ADAR1^f/f^ and CreER; ADAR1^f/f^ mice were subjected to 120 mg/kg tamoxifen (TM) administration(s) as in [Supplementary Figure 1](#sup1){ref-type="supplementary-material"}. Intestinal tissues were harvested at the indicated days (D). (**a**) Upper: *ADAR1* deletion in the intestinal mucosa detected by genomic PCR in ADAR1^f/f^ and CreER; ADAR1^f/f^. The upper and lower bands indicated the deletion of *ADAR1* (Δ) or intact or floxed (f/f) *ADAR1*, respectively. Lower: ADAR1 and *β*-actin protein levels were analyzed by western blotting. (**b**) Representative H&E staining, magnification × 200. (**c**) Representative TUNEL IHC in the small intestine. Arrow heads indicate examples of TUNEL+ cells. (**d**) Quantification of TUNEL staining in the crypts. (**e**) Qualification of active caspase 3 staining in crypts. (**f**) Quantification of TUNEL staining in the colonic crypts. \*\**P*\<0.01, \*\*\**P*\<0.001](cddis2013125f1){#fig1}

![ADAR1 is required for the maintenance and survival of intestinal stem cells. ADAR ^f/f^ or CreER; ADAR^f/f^ mice were subjected to tamoxifen (TM) administration(s) as in [Supplementary Figure 1](#sup1){ref-type="supplementary-material"}. Intestinal tissues were harvested at the indicated days (D). (**a**) *Olfm4* ISH staining (blue), magnification × 200. Lower panels, enlarged views of the selected areas. (**b**) Upper, quantification of *Olfm4* ISH in crypts. Lower, expression of *Lgr5* and *Bmi1* transcripts in isolated crypts was analyzed by real-time RT-PCR. Values are means±S.D. *n*=3 mice in each group. (**c**) Representative pictures of staining of *Olfm4* ISH, TUNEL, and DAPI (nuclei) in crypts on day 3, magnification × 400. Arrow heads indicate examples of *Olfm4*+/TUNEL+ cells. (**d**) Quantification of TUNEL staining in the *Olfm4*+ cells in crypts. (**e**) Expression of *ADAR1, Lgr5, and Bmi1* transcripts in intestinal crypts, Lgr5 high, or Lgr5 low cells was analyzed by real-time RT-PCR. Values are means±S.D.](cddis2013125f2){#fig2}

![*ADAR1* loss impairs intestinal differentiation. ADAR ^f/f^ or CreER; ADAR^f/f^ mice were subjected to tamoxifen (TM) administration(s) as in [Supplementary Figure 1](#sup1){ref-type="supplementary-material"}. Intestinal tissues were harvested at the indicated days (D). (**a**) Representative pictures of Paneth cells, Goblet cells, enteroendocrine cells, and enterocytes examined by differentiation markers MMP7, Muc2, chromogranin A (ChA), and alkaline phosphotase (AP), respectively, magnification × 200. Arrow heads indicate examples of staining positive cells. (**b**) Quantification of MMP7, Muc2, ChA, AP (relative height) staining in the villus. \**P*\<0.05, \*\**P*\<0.01, \*\*\**P*\<0.001. (**c**) Expression of Wnt-regulated genes in the mucosa was analyzed by real-time RT-PCR. \**P*\<0.05, \*\**P*\<0.01. Values are means±S.D. *n*=3 mice in each group. The values were normalized to the ratio of CreER; ADAR^f/f^/ADAR ^f/f^ (ER+*versus* ER- as 1) on day 0 (un). (**d**) TCF4 reporter assays following expression of murine WT ADAR1 and editing mutant 910K/912E at 48 h in HCT 116 colon cancer cells. The TCF-specific relative luciferase activity (RLA) was calculated following normalization to the transfection control and that of the reporter containing mutant TCF-binding sites (Fopflash) set as 1. (**e**) Quantification of BrdU staining. \*\**P*\<0.01. (**f**) Representative pictures of BrdU incorporation (brown), magnification × 400](cddis2013125f3){#fig3}

![ADAR1 deletion rapidly induces endoplasmic reticulum (ER) stress and activation of interferon signaling in intestinal epithelium. ADAR ^f/f^ or CreER; ADAR^f/f^ mice were subjected to 120 mg/kg tamoxifen (TM) administration(s) or the ER stress inhibitor Salubrinal at 1 mg/kg daily, alone, or in combination. Intestinal tissues were harvested at the indicated days (D). (**a**) Bip, CHOP, and *β*-actin levels in the small intestinal mucosa were analyzed by western blotting. (**b**) Quantification of TUNEL staining in the crypts, with or without Salubrinal. (**c**) Quantification of CHOP staining in the crypts, with or without Salubrinal. (**d**) Bip, CHOP, and *β*-actin levels in the small intestinal mucosa at day 3, with or without Salubrinal, were analyzed by western blotting. (**e**) Expression of the indicated interferon-responsive genes in mucosa was analyzed by real-time RT-PCR. \*\**P*\<0.001, \**P*\<0.01, and compared with the control (day 0, Un). (**f**) Expression of the indicated interferon-responsive genes in isolated crypts was analyzed by real-time RT-PCR. \*\**P*\<0.001, \**P*\<0.01, and compared with the control (day 0, Un)](cddis2013125f4){#fig4}

![ADAR1 deletion leads to intestinal inflammation. ADAR ^f/f^ or CreER; ADAR^f/f^ mice were subjected to tamoxifen (TM) administration(s) as in [Supplementary Figure 1](#sup1){ref-type="supplementary-material"}. Intestinal tissues were harvested at the indicated days (D). Quantification of staining of (**a**) neutrophil antigen, (**b**) B220 (B-cell), (**c**) Cd3e (T-cell), and (**d**) myeloid lineage Ly-6G (Gr-1). (**e**) Expression of the indicated inflammatory cytokines in the small intestinal mucosa was analyzed by real-time RT-PCR. (**f**) Expression of the indicated inflammatory cytokines in isolated crypts was analyzed by real-time RT-PCR. Values are means±S.D. *n*=3 mice in each group. The values were normalized to the ratio of CreER; ADAR^f/f^/ADAR ^f/f^ at day 0 (ER+ *versus* ER− as 1, Un). (**e** and **f**) \*\**P*\<0.001, \**P*\<0.01, and compared with the control (day 0)](cddis2013125f5){#fig5}

![Deletion of ADAR1 *in vitro* leads to rapid crypt apoptosis. Small intestinal crypts were isolated from ADAR ^f/f^ or CreER; ADAR^f/f^ mice and plated into Matrigel for 24 h (day 0) as described in methods. Cultured crypts were subjected to DMSO (Un), or 1 nM or 2 nM of tamoxifen (TM) and analyzed 48 h (2 days, 2D) later. (**a**) Representative pictures of cultured intestinal crypts, magnification × 100. Arrow heads indicate crypt budding or growth, which is lacking in CreER; ADAR^f/f^ culture with TM. (**b**) Quantification of apoptosis in cultured crypts by active caspase 3 staining (red). Values are means±S.D. *n*=3 different wells from two different mice in each group. A representative picture of active caspase 3/DAPI staining, magnification × 400. (**c**) The expression of *Lgr5* and *Bmi1* transcripts in the cultured crypt was analyzed by real-time RT-PCR. Values are means±S.D. *n*=3 different wells from three different mice in each group. (**d**) Expression of the indicated Wnt-regulated genes was analyzed by real-time RT-PCR. \*\**P*\<0.01 compared with the control. Values are means±S.D. *n*=3 mice in each group. (**e**) Quantification of CHOP staining in the cultured crypts. Values are means±S.D. *n*=3 mice in each group. (**f**) Expression of the indicated interferon-regulated genes were analyzed by real-time RT-PCR. \**P*\<0.01 compared with the control (DMSO). The values of mRNA levels were normalized to the ratio of CreER; ADAR^f/f^/ADAR ^f/f^ at day 0 (ER+*versus* ER− as 1, Un)](cddis2013125f6){#fig6}
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